Dr Sateesh Apte appointed to Innovative MedTech’s SAB

Innovative MedTech, Inc., a provider of health and wellness services, today announces the expansion of its new scientific advisory board (“SAB”), which will be comprised of leading experts in healthcare and gerontology. Dr Sateesh Apte, MD, will be joining the newly formed SAB.

The Scientific Advisory Board (“SAB”) is expected to play a crucial role in providing strategic guidance and scientific expertise to the Company as it seeks to provide the highest quality of care and to expand its services. The SAB will be responsible for reviewing and evaluating scientific research and best practices related to adult day care, identifying emerging trends and opportunities, assisting the Company with a legislative agenda and developing strategies and recommendations to expand and improve the quality of care provided by the Company.

Dr pte currently serves as the President and CEO of Immgenuity, Inc., a biotechnology company developing immunotherapies to achieve remission in HIV-AIDS. Previously, Dr Apte served as CEO of ImmunoScience, Inc. and was the President, CEO and Medical Director of Alpha Medical Group, Inc., a multispecialty medical group in the San Francisco Bay area overseeing over a dozen clinics and imaging centers representing over 17 medical specialists and primary care physicians.

After medical school, Dr Apte did his graduate training at Haffkine Institute, the Pasteur Institute, Harvard-Longwood Neurology Program at Peter Bent Brigham and affiliated hospitals. Dr Apte then completed a fellowship in Neurology at Stanford University Medical Center. Dr Apte serves on the Scientific Advisory Board of Arev Life Sciences Global Corp, Trility, Inc., Neuropathix, Inc. and Zaaz Therapeutics, Inc. Dr Apte is a member of the American Medical Association, American Academy of Neurology, American Public Health Association, the International AIDS Society and American Association for the Advancement of Science.

“I am excited to join Innovative MedTech as a member of its Scientific Advisory Board. As the population continues to age, the need for quality healthcare provided by the Company is going to grow exponentially and helping with that growth would be challenging but also rewarding,” said Dr Apte. He continued, “Service-based businesses require consistency of care given by diverse locations, and it will be critical to establish standard operating procedures across a vast staff so that the quality of care will be uniformly excellent.”

“I am pleased to welcome Dr Apte to Innovative MedTech. His experience as a medical director of a multispecialty group should be very valuable in establishing medical policies and consistency of care as the Company continues to expand. Dr Apte should be instrumental in guiding medical policy and procedures with an eye towards providing excellent quality of care to our patients,” said Michael Friedman, President of the Company. NewMediaWire